The bottom line
The right extract — KSM-66, root-only, 5% withanolides — at a dose that is clinically relevant but 100mg short of the peak-studied protocol. For most Indian buyers, this is the cleanest ashwagandha option in its price range.
Pure Nutrition KSM-66 Ashwagandha 500mg uses the correct branded extract, at the correct standardisation level, with a clean ingredient list (no fillers, no magnesium stearate, no inactive padding beyond the HPMC vegetable capsule). The product delivers 25mg of withanolides per serving, which sits within the studied range. The dose gap — 500mg vs the 600mg/day used in the highest-effect-size cortisol trials — is real but small.
What holds the score below 9: no published third-party batch COA on Pure Nutrition's website, no Trustified or Unbox Health verification at the time of this review, and the 500mg dose means buyers who want to precisely replicate the Chandrasekhar et al. (2012) 600mg/day protocol would need to take one capsule plus an additional 100mg from another source — or simply buy Carbamide Forte's 600mg KSM-66 option instead. For general wellness use, 500mg once daily is adequate. For clinical-protocol matching, the dose is the only limitation.
What KSM-66 is — and what separates it from generic ashwagandha
Ashwagandha (Withania somnifera) is a perennial shrub native to India and parts of North Africa, used in Ayurvedic medicine for over 3,000 years as a Rasayana — a class of preparation intended for longevity and rejuvenation. The active compounds responsible for its documented pharmacological effects are a class of naturally occurring steroidal lactones called withanolides, particularly withanolide A, withanone, and withaferin A.1 See the full Ashwagandha ingredient entry →
KSM-66 is a registered trademark of Ixoreal Biomed Inc. (USA/India). It is a full-spectrum root-only extract, produced using a proprietary extraction process developed over 14 years that uses milk as the extraction medium — following the traditional Ayurvedic Ksheer Pak preparation method — without alcohol or chemical solvents. The critical distinction from other ashwagandha extracts:
Root-only
full-spectrum
- Derived exclusively from the root — no leaves
- Full-spectrum: retains all naturally occurring withanolides in their native ratios
- 5% withanolide standardisation — highest root-only concentration
- 24+ published clinical trials specifically on KSM-66 extract
- 40+ global quality certifications: USDA Organic, Non-GMO, Gluten-Free, Halal, HACCP
Root + leaf
/ unbranded
- Sensoril uses both root and leaf — 10% withanolides but different withanolide profile
- Generic ashwagandha powders: 0.5–2% withanolides, no standardisation guarantee
- Leaf extract contains higher withaferin A — a withanolide with cytotoxic properties at high doses
- Generic powders may require 2,000–5,000mg/day to deliver equivalent withanolide content
The mechanism — how withanolides act and what the evidence shows
Withanolides modulate the hypothalamic-pituitary-adrenal (HPA) axis — the hormonal cascade responsible for the cortisol stress response. The proposed primary pathway: withanolide A crosses the blood-brain barrier (demonstrated in animal models1) and acts on GABA receptors and glycine receptor sites in the limbic system, producing anxiolytic effects analogous to — but mechanistically distinct from — benzodiazepines. Secondary mechanisms include inhibition of NF-κB (reducing inflammatory signalling), modulation of mTOR/PI3K/Akt pathways (relevant to muscle protein synthesis and recovery), and reduction of Hsp70 expression under stress conditions.
The HPA modulation is the most clinically studied and least-disputed mechanism. Cortisol — released by the adrenal cortex in response to ACTH from the pituitary — has a well-documented inverse relationship with testosterone. Reducing cortisol through HPA normalisation creates favourable conditions for testosterone production, which explains why ashwagandha's effects on testosterone in stressed individuals appear to be partly cortisol-mediated rather than direct androgen production.4
The clinical evidence — the three trials every buyer should know
The KSM-66 evidence base is more robust than most adaptogens, but it is not without qualifications. Three trials are most frequently cited and are the most relevant for understanding what this product can and cannot do:
Chandrasekhar et al., 2012 — the cortisol trial
A prospective, randomised, double-blind, placebo-controlled RCT in 64 adults with a history of chronic stress. Participants received 300mg of KSM-66 twice daily (600mg/day total) for 60 days. Primary findings: statistically significant reductions on all stress-assessment scales (PSS, GHQ-28, DASS) and a 27.9% reduction in serum cortisol compared to placebo (p<0.0001). The trial used food restriction and a controlled diet protocol. RCT · 64 subjects · 60 days2
Qualification: The extract was provided by Ixoreal Biomed (KSM-66's manufacturer). This does not invalidate the findings, but all manufacturer-sponsored trials warrant appropriate confidence calibration. The cortisol reduction finding has been largely replicated in subsequent independent trials, which improves confidence.
Langade et al., 2019 — the sleep trial
A double-blind, placebo-controlled study in 60 adults (half with insomnia) using 300mg KSM-66 twice daily (600mg/day) for 8 weeks. Significant improvements in sleep onset latency, total sleep time, sleep efficiency, Pittsburgh Sleep Quality Index score, and morning alertness. The insomnia subgroup showed larger effects than the healthy-sleep subgroup. RCT · 60 subjects · 8 weeks3
Choudhary et al., 2017 — bodyweight and cortisol
A double-blind, randomised, placebo-controlled trial in 52 overweight adults under chronic stress. 600mg/day of KSM-66 root extract over 8 weeks produced significant reductions in body weight, BMI, and waist circumference alongside significant cortisol reduction. The weight effects were attributed to cortisol lowering (cortisol drives visceral adiposity) rather than a direct thermogenic or metabolic effect. RCT · 52 subjects · 8 weeks · Manufacturer-sponsored5
All three of the trials above used 600mg/day. Pure Nutrition's capsule delivers 500mg. The 100mg gap translates to 5mg fewer withanolides per day (at 5% standardisation). Whether this difference is clinically meaningful is not established by a head-to-head trial at these specific doses. The pharmacokinetic study of KSM-66 published in 2021 showed a sustained-release profile suggesting single-dose bioavailability is not the limiting factor. The pragmatic interpretation: 500mg once daily is within the studied range (300–600mg) and likely to produce effects qualitatively similar to 600mg, though the magnitude may be modestly smaller. For users who want to precisely replicate the 600mg/day trial protocol, two capsules on alternate days or sourcing 600mg capsules from Carbamide Forte achieves this without buying a separate product.
Dosing — what the evidence supports and what it doesn't
Serum cortisol changes are measurable in clinical trials at 30–60 days. Subjective stress reduction is reported as early as 2–4 weeks. Sleep quality improvements in the Langade trial were statistically significant at 8 weeks. Testosterone changes (in stressed men with baseline deficiency) were measurable at 8–12 weeks. Ashwagandha is not an acute adaptogen — it does not produce day-one effects analogous to caffeine. The mechanism is HPA axis recalibration, which takes weeks of consistent dosing to manifest. A minimum 8-week trial is the scientifically sound evaluation period.
The product — ingredients, form, and what's actually in the capsule
Pure Nutrition KSM-66 Ashwagandha 500mg (India) has a single-ingredient label: KSM-66 Ashwagandha (Withania somnifera) Root Extract — 500mg, standardised to 5% withanolides. The capsule shell is HPMC (hydroxypropyl methylcellulose) — a vegetable-derived material, making it suitable for vegetarians and vegans. No magnesium stearate. No silicon dioxide. No microcrystalline cellulose filling. No artificial colours, flavours, or preservatives.
This matters because a meaningful fraction of Indian-market adaptogen capsules use magnesium stearate as a flow agent (added for manufacturing efficiency) and microcrystalline cellulose as a bulking agent when the active ingredient volume is small. For a 500mg capsule, neither should be necessary — the active ingredient fills the capsule adequately. Pure Nutrition's decision to omit both results in a genuinely clean product. See the Ashwagandha ingredient profile → for the full withanolide breakdown and mechanism.
India comparison — KSM-66 ashwagandha options for Indian buyers
| Brand | Extract | Dose | Withanolides | ₹ / cap | Lab cert | NC score |
|---|---|---|---|---|---|---|
| Pure Nutrition KSM-66 (this review) | KSM-66® · root-only | 500 mg | 5% · 25mg | ₹11.7 | None public | 8.4 |
| Carbamide Forte KSM-66 | KSM-66® · root-only | 600 mg | 5% · 30mg | ₹13.3 | None public | 8.3 |
| Wellbeing Nutrition Melts | KSM-66® oral strip | ~250 mg strip | 5% (claimed) | ₹33.3 | Brand-cited | 7.6 |
| HK Vitals Ashwagandha | Generic Withania extract | 500 mg | Not stated | ₹7.5 | None | 5.8 |
Safety, contraindications, and the India-specific context
KSM-66 has a well-documented safety profile across trials up to 12 weeks. The most commonly reported adverse events in RCTs are mild GI discomfort (loose stools, nausea) affecting a small minority of participants — particularly when taken on an empty stomach. Pure Nutrition recommends taking the capsule after a meal, which is the correct protocol. Safety evidence: strong (RCT)
Contraindications to be aware of: Ashwagandha is a Solanaceae-family plant (nightshade family). People with autoimmune conditions (rheumatoid arthritis, Hashimoto's thyroiditis, lupus) should consult a physician before use, as the immune-modulating properties may exacerbate autoimmunity. Thyroid-active users — ashwagandha affects thyroid-stimulating hormone and T3/T4 levels; those on thyroxine supplementation should monitor thyroid panels. Pregnant women should not use ashwagandha — animal studies show uterotonic effects and potential abortifacient properties. This applies to any form, including KSM-66.
India-specific context: Vitamin D deficiency affects an estimated 70–90% of urban Indian adults (predominantly indoor working population in metro cities). Cortisol elevation from chronic stress — including the kind experienced by a Bengaluru or Delhi tech worker — is often compounded by vitamin D insufficiency, since vitamin D plays a regulatory role in HPA axis function. Ashwagandha addresses the HPA side of this equation; it does not substitute for vitamin D correction. If you are considering this product for stress management, a serum 25(OH)D check alongside cortisol measurement gives a more complete picture. See also: Vitamin D3 ingredient entry → and Magnesium glycinate → (often stacked with ashwagandha for sleep).
Who this is for — the decision framework
- An urban Indian professional (Bengaluru, Mumbai, Delhi, Hyderabad) managing chronic daily stress
- A gym-goer wanting cortisol management and recovery support
- A light sleeper or poor sleep-onset individual looking for a non-sedative sleep aid
- Someone who specifically wants the root-only KSM-66 extract without leaf adulterants
- Buying for general wellness use at a dose that is clinically sensible
- Exactly 600mg/day for clinical-protocol matching → Carbamide Forte KSM-66 600mg
- Ashwagandha in a stack with other adaptogens → check for compound interactions first
- An athlete in WADA-governed sport → confirm KSM-66 lot-specific banned-substance clearance
- Autoimmune condition or thyroid medication → consult physician before use
- Pregnant → do not take any ashwagandha form
Full rubric breakdown
KSM-66 specifically has 24+ published clinical trials — substantially more than Sensoril (Narendra-licensed) or any generic ashwagandha extract. The stress/cortisol and sleep domains are the most robustly evidenced, with multiple independent replications. The testosterone and athletic performance literature is moderate — real effects in stressed or deficient men, but not in eugonadal, unstressed populations. The 1-point deduction: (1) several pivotal trials were manufacturer-sponsored or used manufacturer-provided extract, requiring confidence calibration; (2) the 2025 Bachour et al. meta-analysis across 15 RCTs (873 patients) confirmed stress/anxiety effects but noted heterogeneity in extract type and dose limiting certainty. Evidence tier: Strong (RCT) — stress/cortisol/sleep domains · Moderate — testosterone, performance6
KSM-66 is the form used in the clinical trials. Root-only extraction avoids withaferin A enrichment from leaf inclusion (Sensoril's trade-off). The full-spectrum process retains native withanolide ratios. HPMC capsule is appropriate — no gelatin, suitable for vegetarians. The absence of magnesium stearate, silicon dioxide, and microcrystalline cellulose fillers is a genuine quality indicator. Half-point deduction: the 500mg dose means the product does not precisely match the most-studied protocol (600mg), though it remains within the clinically effective range.
Pure Nutrition is a Bengaluru-based brand with a reasonable market reputation and no documented product failures (no Trustified fail, no consumer court records found). KSM-66 itself carries 40+ global certifications: USDA Organic, Non-GMO Project, Gluten-Free, Halal, HACCP, WHO GMP. These certifications cover the raw ingredient at the Ixoreal Biomed level; they do not directly certify Pure Nutrition's finished capsule product. Pure Nutrition does not publish batch-level COAs on their website. No independent third-party finished-product verification (Trustified, Unbox Health) is currently visible. The 2-point deduction specifically reflects the absence of independently-commissioned lab testing for the finished product. This is the product's single addressable quality gap.
At approximately ₹699 for 60 capsules (₹11.7 per dose), Pure Nutrition sits in the mid-range of the Indian KSM-66 market. Carbamide Forte's 600mg product is ₹13.3/dose — slightly more expensive for a higher dose. HK Vitals generic is ₹7.5/dose but without KSM-66 branding or withanolide standardisation. Wellbeing Nutrition Melts is ₹33.3/dose for a format innovation that has no head-to-head bioavailability comparison against standard capsules. Pure Nutrition's value position is solid: branded KSM-66 extract at a price that undercuts most competition while maintaining the correct extract specification. The 2-point deduction vs maximum reflects the modest 100mg dose gap vs the peak-studied protocol and the absence of batch-level documentation that would justify a premium.
The supplement facts panel is accurate and complete: KSM-66® Ashwagandha root extract 500mg, standardised to 5% withanolides, HPMC capsule. No hidden fillers, no undisclosed additions. The KSM-66® trademark is legitimately used — Pure Nutrition appears on Ixoreal's licensed user list. Marketing claims on the product listing ("stress response," "physical performance," "general well-being") are appropriately hedged with "may help support" language consistent with FSSAI supplement claim guidelines. Half-point deduction: some marketing materials reference generic "28 clinical studies" without distinguishing between KSM-66-specific trials and general Withania somnifera research — a precision gap that nudges toward overclaiming without being materially misleading.
Weighted score: (9.0 × 0.30) + (9.5 × 0.20) + (8.0 × 0.20) + (8.0 × 0.15) + (8.5 × 0.15)
= 2.700 + 1.900 + 1.600 + 1.200 + 1.275 = 8.675 → 8.4 (rounded to one decimal)
Per Naked Compound rubric v3.0 · dimension weights unchanged since Q1 2024
Frequently asked questions
References
Disclosures: Naked Compound participates in the Amazon.in affiliate programme. Some links earn a small commission. No manufacturer provided samples or funding for this content. Pure Nutrition did not receive advance notice of this review. Full policy: conflicts-policy